UNH Stock Chart & Stats
€367.40
€4.40(1.20%)
At close: 4:00 PM EDT
€367.40
€4.40(1.20%)
Day’s Range― - ―
52-Week Range€204.50 - €400.60
Previous CloseN/A
Volume1.35K
Average Volume (3M)1.44K
Market Cap
€326.21B
Enterprise Value€451.32K
Total Cash (Recent Filing)€31.47B
Total Debt (Recent Filing)€73.33B
Price to Earnings (P/E)26.6
Beta-0.18
Next Earnings
Oct 09, 2026EPS Estimate
3.55Next Dividend Ex-DateN/A
Dividend Yield2.11%
Share Statistics
EPS (TTM)15.55
Shares Outstanding908,144,400
10 Day Avg. Volume1,736
30 Day Avg. Volume1,440
Financial Highlights & Ratios
PEG Ratio-1.62
Price to Book (P/B)3.19
Price to Sales (P/S)0.67
P/FCF Ratio18.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€414.71Price Target Upside12.88% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering21
EPS Forecast (FY)17.16
Revenue Forecast (FY)€389.15B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationSustained, high free cash flow (~$23.6B TTM) and strong conversion (~85%) provide durable financial flexibility. That cash funds capex, technology and care investments, dividends and sizable buybacks while supporting balance-sheet resilience through cycles.
Scale And Optum Operational MomentumOptum's broad scale across care delivery, pharmacy and analytics is a durable competitive advantage. High retention, expanded geographic reach, and measurable care/cost improvements embed long-term revenue stickiness and create multiple levers to improve outcomes and margins.
Consistent Revenue Growth And ScaleSustained ~9% TTM revenue growth across UnitedHealthcare and Optum increases negotiating leverage with providers and vendors, funds ongoing investments in technology and care models, and supports structural operating-leverage potential as scale expands.
Bears Say
Sustained Margin CompressionMaterial decline in reported margins versus prior years signals weaker earnings power. If higher costs or mix shifts persist, profitability will remain constrained and the company will need durable underwriting improvements or efficiency gains to restore historical returns.
Elevated Commercial Medical Cost TrendsStructural upward pressure on medical costs (provider pricing, coding intensity, specialty drugs) can persistently erode underwriting margins. Without sustained pricing actions, network changes or care-model offsets, these trends delay margin recovery for multiple years.
TTM Balance-sheet Data InconsistencyA reported TTM inconsistency in shareholders' equity undermines confidence in the most recent balance-sheet snapshot. That complicates credit assessment, covenant monitoring and capital-allocation transparency until reconciled, creating a persistent governance/ disclosure risk.
UnitedHealth News
UNH FAQ
What was UnitedHealth’s price range in the past 12 months?
UnitedHealth lowest stock price was €204.50 and its highest was €400.60 in the past 12 months.
What is UnitedHealth’s market cap?
UnitedHealth’s market cap is €326.21B.
When is UnitedHealth’s upcoming earnings report date?
UnitedHealth’s upcoming earnings report date is Oct 09, 2026 which is in 67 days.
How were UnitedHealth’s earnings last quarter?
UnitedHealth released its earnings results on Jul 16, 2026. The company reported €5.57 earnings per share for the quarter, beating the consensus estimate of €4.284 by €1.286.
Is UnitedHealth overvalued?
According to Wall Street analysts UnitedHealth’s price is currently Undervalued.
Does UnitedHealth pay dividends?
UnitedHealth pays a Quarterly dividend of €2.013 which represents an annual dividend yield of 2.11%. See more information on UnitedHealth dividends here
What is UnitedHealth’s EPS estimate?
UnitedHealth’s EPS estimate is 3.55.
How many shares outstanding does UnitedHealth have?
UnitedHealth has 908,144,400 shares outstanding.
What happened to UnitedHealth’s price movement after its last earnings report?
UnitedHealth reported an EPS of €5.57 in its last earnings report, beating expectations of €4.284. Following the earnings report the stock price went up 2.38%.
Which hedge fund is a major shareholder of UnitedHealth?
Currently, no hedge funds are holding shares in DE:UNH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
UnitedHealth Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€414.71 (12.88% Upside)
€414.71 (12.88% Upside)
Blogger Sentiment
Bullish
DE:UNH Sentiment 85%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 80%
Bearish news 20%
Bearish news 20%
Technicals
SMA
Positive
20 days / 200 days
Momentum
55.07%
12-Months-Change
Fundamentals
Return on Equity
2.11%
Trailing 12-Months
Asset Growth
0.37%
Trailing 12-Months
Company Description
UnitedHealth
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.
UNH Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call reflects a broadly positive tone: strong quarter-to-date financial results (notably double-digit EPS growth and raised guidance), solid operational progress across Optum (AI-led efficiency gains, improved care metrics), and meaningful shareholder returns and balance sheet improvement. However, the company faces notable near-term headwinds—elevated commercial medical cost trends, pressured Medicaid margins, Medicare enrollment declines, and some one-time favorable prior-period development—creating areas of ongoing focus and uncertainty. On balance, the positive developments and upgraded outlook outweigh the challenges, but management emphasizes continued urgency and investment to sustain improvement.View all DE:UNH earnings summariesUNH Revenue Breakdown
78.70% Premiums
11.93% Products
8.50% Services
0.88% Investment and other income
UNH Stock 12 Month Forecast
Average Price Target
€414.71
▲(12.88% Upside)